Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the insulin, cancer, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze(TM) technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. The company has key partnerships with Roche, Baxter, ViroPharma and Intrexon to apply Enhanze technology to therapeutic biologics including Herceptin , MabThera , immunoglobulin, Cinryze and alpha 1-antitrypsin. Halozyme's Ultrafast Insulin program combines its rHuPH20 enzyme with mealtime insulins, which may produce more rapid absorption, faster action, and improved glycemic control. The product candidates in Halozyme's pipeline target multiple areas of significant unmet medical need.Founded in 1998, Halozyme is an established company that loves to hire graduates from San Diego State University, with 23.1% of its employees having attended San Diego State University. Halozyme has established itself as a great place to work in California, and it is number 7 on Zippia's list of Best Companies to Work for in San Diego, CA.The average employee at Halozyme makes $93,996 per year, which is competitive for its industry and location. Some of its highest paying competitors, Gilead Sciences, Genentech, and Alder Biopharmaceuticals, pay $99,828, $97,473, and $94,428, respectively.Halozyme is a small health care company based in San Diego, CA with only 136 employees and an annual revenue of $660.0M.
Halozyme's Mission Statement
We are driven to bring innovative and disruptive solutions and support to partners with a goal of significantly improving patient experiences, and potentially outcomes, for emerging and established therapies.
Halozyme is ranked #25 on the Best Health Care Companies to Work For in California list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
The average a Halozyme salary in the United States is $93,996 per year.
Halozyme employees in the top 10 percent can make over $147,000 per year,
while Halozyme employees at the bottom 10 percent earn less than $59,000 per year.
Average Halozyme Salary
$93,996
yearly
$45.19 hourly
Updated March 14, 2024
Rate the fairness of Halozyme's compensation policies.
Halozyme diversity
9.3
Diversity Score
We calculated Halozyme’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Halozyme’s workforce.
Do you work at Halozyme?
Were you satisfied with Halozyme's salary and benefits?
Halozyme Financial Performance
9.9
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Halozyme currently has 660.1M in revenue. Halozyme's most recent quarter produced 221.0m (q2'2023).
Halozyme annual revenue
$660M
$528M
$396M
$264M
$132M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Highest paying Halozyme competitors
Compare Halozyme salaries to competitors, including Gilead Sciences, Genentech, and Alder Biopharmaceuticals. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Genentech average $97,473 per year, and the salaries at Alder Biopharmaceuticals come in at $94,428 per year.
Zippia gives an in-depth look into the details of Halozyme, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Halozyme. The employee data is based on information from people who have self-reported their past or current employments at Halozyme. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Halozyme. The data presented on this page does not represent the view of Halozyme and its employees or that of Zippia.
Halozyme may also be known as or be related to HALOZYME THERAPEUTICS INC., Halozyme, Halozyme Inc, Halozyme Therapeutics Inc, Halozyme Therapeutics, Inc. and Halozyme, Inc.